144 related articles for article (PubMed ID: 15769460)
1. Hypertensive target organ damage is attenuated by a p38 MAPK inhibitor: role of systemic blood pressure and endothelial protection.
Olzinski AR; McCafferty TA; Zhao SQ; Behm DJ; Eybye ME; Maniscalco K; Bentley R; Frazier KS; Milliner CM; Mirabile RC; Coatney RW; Willette RN
Cardiovasc Res; 2005 Apr; 66(1):170-8. PubMed ID: 15769460
[TBL] [Abstract][Full Text] [Related]
2. p38 MAPK inhibitors ameliorate target organ damage in hypertension: Part 1. p38 MAPK-dependent endothelial dysfunction and hypertension.
Ju H; Behm DJ; Nerurkar S; Eybye ME; Haimbach RE; Olzinski AR; Douglas SA; Willette RN
J Pharmacol Exp Ther; 2003 Dec; 307(3):932-8. PubMed ID: 14561851
[TBL] [Abstract][Full Text] [Related]
3. Contribution of cytochrome P450 metabolites of arachidonic acid to hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME.
Benter IF; Francis I; Cojocel C; Juggi JS; Yousif MH; Canatan H
Auton Autacoid Pharmacol; 2005 Oct; 25(4):143-54. PubMed ID: 16176445
[TBL] [Abstract][Full Text] [Related]
4. p38 MAPK inhibitors ameliorate target organ damage in hypertension: Part 2. Improved renal function as assessed by dynamic contrast-enhanced magnetic resonance imaging.
Lenhard SC; Nerurkar SS; Schaeffer TR; Mirabile RC; Boyce RW; Adams DF; Jucker BM; Willette RN
J Pharmacol Exp Ther; 2003 Dec; 307(3):939-46. PubMed ID: 14561850
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape.
Hu L; Sealey JE; Chen R; Zhou Y; Merali C; Shi Y; Laragh JH; Catanzaro DF
Am J Hypertens; 2004 May; 17(5 Pt 1):395-403. PubMed ID: 15110897
[TBL] [Abstract][Full Text] [Related]
6. Effects of p38 MAPK Inhibitor on angiotensin II-dependent hypertension, organ damage, and superoxide anion production.
Bao W; Behm DJ; Nerurkar SS; Ao Z; Bentley R; Mirabile RC; Johns DG; Woods TN; Doe CP; Coatney RW; Ohlstein JF; Douglas SA; Willette RN; Yue TL
J Cardiovasc Pharmacol; 2007 Jun; 49(6):362-8. PubMed ID: 17577100
[TBL] [Abstract][Full Text] [Related]
7. Short-term ACE inhibition confers long-term protection against target organ damage.
Hale TM; Robertson SJ; Burns KD; deBlois D
Hypertens Res; 2012 Jun; 35(6):604-10. PubMed ID: 22318205
[TBL] [Abstract][Full Text] [Related]
8. Effects of nitric oxide synthase inhibition on angiotensin receptors and metabolism in the pregnant hypertensive rat.
Yang Y; Macdonald GJ; Duggan KA
Clin Sci (Lond); 2001 Mar; 100(3):319-26. PubMed ID: 11222119
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants on rat chromosome 8 exhibit profound effects on hypertension severity and survival during nitric oxide inhibition in spontaneously hypertensive rats.
Schulz A; Schütten-Faber S; Schulte L; Unland J; Kossmehl P; Kreutz R
Am J Hypertens; 2014 Mar; 27(3):294-8. PubMed ID: 24363279
[TBL] [Abstract][Full Text] [Related]
10. Effects of chronic increased salt intake on nitric oxide synthesis inhibition-induced hypertension.
Fernández-Rivas A; García-Estañ J; Vargas F
J Hypertens; 1995 Jan; 13(1):123-8. PubMed ID: 7759842
[TBL] [Abstract][Full Text] [Related]
11. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM
Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide-independent stimulation of soluble guanylate cyclase reduces organ damage in experimental low-renin and high-renin models.
Sharkovska Y; Kalk P; Lawrenz B; Godes M; Hoffmann LS; Wellkisch K; Geschka S; Relle K; Hocher B; Stasch JP
J Hypertens; 2010 Aug; 28(8):1666-75. PubMed ID: 20613628
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide inhibition accelerates hypertension and induces perivascular inflammation in rats.
Hsieh NK; Wang JY; Liu JC; Wang SD; Chen HI
Clin Exp Pharmacol Physiol; 2004 Apr; 31(4):212-8. PubMed ID: 15053816
[TBL] [Abstract][Full Text] [Related]
14. Enalapril attenuates cardiorenal damage in nitric-oxide-deficient spontaneously hypertensive rats.
Pereira LM; Bezerra DG; Machado DL; Mandarim-de-Lacerda CA
Clin Sci (Lond); 2004 Mar; 106(3):337-43. PubMed ID: 14629192
[TBL] [Abstract][Full Text] [Related]
15. Treatment with the arginase inhibitor N(omega)-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat.
Bagnost T; Berthelot A; Bouhaddi M; Laurant P; André C; Guillaume Y; Demougeot C
J Hypertens; 2008 Jun; 26(6):1110-8. PubMed ID: 18475148
[TBL] [Abstract][Full Text] [Related]
16. Genetic locus on MWF rat chromosome 6 affects kidney damage in response to L-NAME treatment in spontaneously hypertensive rats.
Schulz A; Schütten S; Schulte L; Kossmehl P; Nyengaard JR; Vetter R; Huber M; Kreutz R
Physiol Genomics; 2010 Jun; 42(1):126-33. PubMed ID: 20388842
[TBL] [Abstract][Full Text] [Related]
17. P38 MAPK inhibitors suppress biomarkers of hypertension end-organ damage, osteopontin and plasminogen activator inhibitor-1.
Nerurkar SS; Olzinski AR; Frazier KS; Mirabile RC; O'Brien SP; Jing J; Rajagopalan D; Yue TL; Willette RN
Biomarkers; 2007; 12(1):87-112. PubMed ID: 17438656
[TBL] [Abstract][Full Text] [Related]
18. L-arginine fails to protect against myocardial remodelling in L-NAME-induced hypertension.
Simko F; Luptak I; Matuskova J; Krajcirovicova K; Sumbalova Z; Kucharska J; Gvozdjakova A; Simko J; Babal P; Pechanova O; Bernatova I
Eur J Clin Invest; 2005 Jun; 35(6):362-8. PubMed ID: 15948896
[TBL] [Abstract][Full Text] [Related]
19. Valsartan improves L-NAME-exacerbated cardiac fibrosis with TGF-ß inhibition and apoptosis induction in spontaneously hypertensive rats.
Akashiba A; Ono H; Ono Y; Ishimitsu T; Matsuoka H
J Cardiol; 2008 Dec; 52(3):239-46. PubMed ID: 19027602
[TBL] [Abstract][Full Text] [Related]
20. Chronic N-acetylcysteine administration prevents development of hypertension in N(omega)-nitro-L-arginine methyl ester-treated rats: the role of reactive oxygen species.
Rauchová H; Pechánová O; Kunes J; Vokurková M; Dobesová Z; Zicha J
Hypertens Res; 2005 May; 28(5):475-82. PubMed ID: 16156512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
